Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioklone
Chennai, Tamil Nadu, Indiabioklone.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Commercial
01
Overview
Bioklone specializes in custom development of polyclonal and monoclonal antibodies for research, diagnostic, and pharmaceutical applications. The company has developed over 1000 custom antibodies to various antigens including proteins with specific modifications. Notably, it received funding under the National Biopharma Mission for developing human monoclonal antibodies against SARS-CoV‑2 from convalescent patient blood during the COVID‑19 pandemic. Its services include assay development for PK/ADA studies supporting biosimilar and drug candidate assessment. No direct evidence of proprietary therapeutics in clinical trials was found.
- Therapeutic areas
- OncologyCardiovascularRare DiseasesInfectious Diseases
- Modalities
- Monoclonal antibodyPolyclonal antibodyHuman monoclonal antibody
- Industry
- Drug Discovery Services
02
Partnerships
No major disclosed pharma or biotech partnerships; received government funding via National Biopharma Mission/BIRAC during COVID‑19 response.
Beyond the preview
Go deeper on Bioklone.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bioklone.